Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat,Ehssan Moglad,Muhammad Afzal,Riya Thapa,Waleed Hassan Almalki,Imran Kazmi,Sami I. Alzarea,Haider Ali,Kumud Pant,Thakur Gurjeet Singh,Harish Dureja,Sachin Kumar Singh,Kamal Dua,Gaurav Gupta,Vetriselvan Subramaniyan
DOI: https://doi.org/10.1111/cns.70053
2024-10-22
CNS Neuroscience & Therapeutics
Abstract:Huntington's disease (HD) is a progressive neurodegenerative disorder marked by the gradual decline in physical, cognitive, and mental functions, with aging exacerbating the pathogenic effects of mutant huntingtin (mHTT) protein aggregation. Cellular senescence, driven by mHTT accumulation, contributes to HD pathophysiology through processes like DNA damage, oxidative stress, and inflammation, which worsen neuronal damage. Understanding the interplay between aging, mHTT toxicity, and cellular senescence offers potential therapeutic avenues to mitigate the impact of HD and improve patient outcomes. Huntington's disease (HD) is a devastating neurodegenerative disease that is manifested by a gradual loss of physical, cognitive, and mental abilities. As the disease advances, age has a major impact on the pathogenic signature of mutant huntingtin (mHTT) protein aggregation. This review aims to explore the intricate relationship between aging, mHTT toxicity, and cellular senescence in HD. Scientific data on the interplay between aging, mHTT, and cellular senescence in HD were collected from several academic databases, including PubMed, Google Scholar, Google, and ScienceDirect. The search terms employed were "AGING," "HUNTINGTON'S DISEASE," "MUTANT HUNTINGTIN," and "CELLULAR SENESCENCE." Additionally, to gather information on the molecular mechanisms and potential therapeutic targets, the search was extended to include relevant terms such as "DNA DAMAGE," "OXIDATIVE STRESS," and "AUTOPHAGY." According to research, aging leads to worsening HD pathophysiology through some processes. As a result of the mHTT accumulation, cellular senescence is promoted, which causes DNA damage, oxidative stress, decreased autophagy, and increased inflammatory responses. Pro‐inflammatory cytokines and other substances are released by senescent cells, which may worsen the neuronal damage and the course of the disease. It has been shown that treatments directed at these pathways reduce some of the HD symptoms and enhance longevity in experimental animals, pointing to a new possibility of treating the condition. Through their amplification of the harmful effects of mHTT, aging and cellular senescence play crucial roles in the development of HD. Comprehending these interplays creates novel opportunities for therapeutic measures targeted at alleviating cellular aging and enhancing HD patients' quality of life.
pharmacology & pharmacy,neurosciences